Beihai Gofar Marine Biological Industry Co Ltd (SHG:600538) — Market Cap & Net Worth
Market Cap & Net Worth: Beihai Gofar Marine Biological Industry Co Ltd (600538)
Beihai Gofar Marine Biological Industry Co Ltd (SHG:600538) has a market capitalization of $375.86 Million (CN¥2.57 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #13889 globally and #4192 in its home market, demonstrating a -1.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beihai Gofar Marine Biological Industry Co Ltd's stock price CN¥4.90 by its total outstanding shares 524198348 (524.20 Million). Also see Beihai Gofar Marine Biological Industry asset portfolio for a full breakdown of the balance sheet.
Beihai Gofar Marine Biological Industry Co Ltd Market Cap History: 2015 to 2026
Beihai Gofar Marine Biological Industry Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $908.97 Million to $375.86 Million (-5.30% CAGR). Also see 600538 cash generation efficiency for how efficiently the company converts equity into cash flow.
Beihai Gofar Marine Biological Industry Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beihai Gofar Marine Biological Industry Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Beihai Gofar Marine Biological Industry stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.43x
Beihai Gofar Marine Biological Industry Co Ltd's market cap is 1.43 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.05 Billion | $263.22 Million | -$31.86 Million | 3.97x | N/A |
| 2017 | $428.02 Million | $232.06 Million | $8.85 Million | 1.84x | 48.36x |
| 2018 | $329.84 Million | $224.52 Million | -$21.61 Million | 1.47x | N/A |
| 2019 | $388.14 Million | $251.15 Million | $5.77 Million | 1.55x | 67.23x |
| 2020 | $452.57 Million | $267.70 Million | $3.20 Million | 1.69x | 141.40x |
| 2021 | $463.31 Million | $424.72 Million | $10.49 Million | 1.09x | 44.18x |
| 2022 | $346.71 Million | $459.68 Million | $34.84 Million | 0.75x | 9.95x |
| 2023 | $355.92 Million | $369.15 Million | -$82.31 Million | 0.96x | N/A |
| 2024 | $395.81 Million | $340.47 Million | -$93.85 Million | 1.16x | N/A |
| 2025 | $469.45 Million | $328.24 Million | -$87.62 Million | 1.43x | N/A |
Competitor Companies of 600538 by Market Capitalization
Companies near Beihai Gofar Marine Biological Industry Co Ltd in the global market cap rankings as of September 24, 2026. Review Beihai Gofar Marine Biological Industry tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Beihai Gofar Marine Biological Industry Co Ltd by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #547 globally with a market cap of $50.57 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #756 globally with a market cap of $36.67 Billion USD ( CA$50.69 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1333 globally with a market cap of $19.26 Billion USD ( CN¥131.60 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1503 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #547 | Corteva Inc | NYSE:CTVA | $50.57 Billion | $80.34 |
| #756 | Nutrien Ltd | TO:NTR | $36.67 Billion | CA$106.23 |
| #1333 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $19.26 Billion | CN¥24.87 |
| #1503 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $120.59 |
Beihai Gofar Marine Biological Industry Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Beihai Gofar Marine Biological Industry Co Ltd's market cap moved from $908.97 Million to $ 375.86 Million, with a yearly change of -5.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥375.86 Million | -19.93% |
| 2025 | CN¥469.45 Million | +18.60% |
| 2024 | CN¥395.81 Million | +11.21% |
| 2023 | CN¥355.92 Million | +2.65% |
| 2022 | CN¥346.71 Million | -25.17% |
| 2021 | CN¥463.31 Million | +2.37% |
| 2020 | CN¥452.57 Million | +16.60% |
| 2019 | CN¥388.14 Million | +17.67% |
| 2018 | CN¥329.84 Million | -22.94% |
| 2017 | CN¥428.02 Million | -59.09% |
| 2016 | CN¥1.05 Billion | +15.11% |
| 2015 | CN¥908.97 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Beihai Gofar Marine Biological Industry Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $375.86 Million USD |
| MoneyControl | $375.86 Million USD |
| MarketWatch | $375.86 Million USD |
| marketcap.company | $375.86 Million USD |
| Reuters | $375.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, phar… Read more